KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt repayments

Daily Values

Growth Metrics

Others

Nu Skin Enterprises (NUS) Gains from Sales and Divestitures (2016 - 2025)

Nu Skin Enterprises' Gains from Sales and Divestitures history spans 13 years, with the latest figure at $48200.0 for Q4 2025.

On a quarterly basis, Gains from Sales and Divestitures fell 87.5% to $48200.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $48200.0, a 87.5% decrease, with the full-year FY2025 number at $48200.0, down 87.5% from a year prior.
Gains from Sales and Divestitures hit $48200.0 in Q4 2025 for Nu Skin Enterprises, down from $385700.0 in the prior quarter.
Over the last five years, Gains from Sales and Divestitures for NUS hit a ceiling of $385700.0 in Q4 2024 and a floor of $48200.0 in Q4 2025.
Historically, Gains from Sales and Divestitures has averaged $247166.7 across 3 years, with a median of $307600.0 in 2021.
Biggest five-year swings in Gains from Sales and Divestitures: surged 39.75% in 2021 and later crashed 87.5% in 2025.
Tracing NUS's Gains from Sales and Divestitures over 3 years: stood at $307600.0 in 2021, then increased by 25.39% to $385700.0 in 2024, then crashed by 87.5% to $48200.0 in 2025.
Business Quant data shows Gains from Sales and Divestitures for NUS at $48200.0 in Q4 2025, $385700.0 in Q4 2024, and $307600.0 in Q4 2021.